+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Microbiome Sequencing Services Market Report and Forecast 2024-2032

  • PDF Icon

    Report

  • 140 Pages
  • September 2023
  • Region: Global
  • Expert Market Research
  • ID: 5895114
The global microbiome sequencing services market was valued USD 2.2 billion in 2023, driven by the rising awareness, technological advancements, research and development. The market size is anticipated to grow at a CAGR of 20.8% during the forecast period of 2024-2032 to achieve a value of USD 12.1 billion by 2032.

Microbiome Sequencing Services: Introduction

The microbiome refers to the complex community of microorganisms, including bacteria, fungi, protozoa, and viruses, that live on and inside the human body, especially in the gut. These microbial communities play essential roles in human health and disease. Understanding the composition and functionality of these communities has been the focus of numerous studies in recent years, and microbiome sequencing has emerged as a crucial tool to achieve this. Microbiome sequencing services encompass a set of techniques and methods employed to analyze the genetic material of microorganisms present in each sample, revealing insights about the type, abundance, and function of these microbes.

Key Trends in the Global Microbiome Sequencing Services Market

  • Increased Funding and Investment: As the significance of the microbiome in various sectors becomes evident, there's a rise in funding from both public and private sectors to support microbiome research.
  • Technological Advancements: The introduction of next-generation sequencing (NGS) technologies has allowed for more in-depth, accurate, and faster sequencing. Cost reductions in sequencing technologies also enable more extensive studies.
  • Focus on Personalized Medicine: Understanding individual microbiomes can potentially lead to personalized treatment plans, especially for conditions like gut disorders, metabolic disorders, and even some neurological conditions.
  • Rise of Direct-to-Consumer Microbiome Tests: There's an increasing trend of companies offering direct microbiome testing services to consumers, giving insights into their gut health, dietary recommendations, and more.

Global Microbiome Sequencing Services Market Segmentations

The market can be categorised into product and services, technology, applications, end user and region.

Market Breakup by Products and Services

  • Reagents & Consumables
  • Instruments
  • Services

Market Breakup by Technology

  • Sequencing by Synthesis
  • Sequencing by Ligation
  • Shotgun Sequencing
  • Sanger Sequencing
  • Pyrosequencing
  • Other Technologies

Market Breakup by Applications

  • Drug Development
  • Agriculture and Food Industry
  • Environmental Monitoring
  • Others

Market Breakup by End User

  • Academic and Research Institutes
  • Pharmaceutical and Biotechnology Companies
  • Contract Research Organizations (CROs)
  • Others

Market Breakup by Region

  • North America
  • Europe
  • Asia Pacific
  • Latin America
  • Middle East and Africa

Global Microbiome Sequencing Services Market Overview

The microbiome sequencing services market is an ever-evolving sector driven by advancements in genomics and a deepening understanding of the critical role the microbiome plays in health, disease, and environmental interactions. Microbiome sequencing services involve the use of specialized techniques to sequence and analyse the genetic material of microbial communities found in different environments, particularly the human body, to understand their composition, functionality, and interaction with their host or environment. The market comprises a mix of specialized microbiome companies, large sequencing service providers, and academic and research institutions. Key players often engage in partnerships, collaborations, and M&A activities to expand their service offerings and geographical reach.

Regional Overview:

  • North America: One of the largest markets due to advanced healthcare infrastructure, significant R&D investments, and heightened awareness.
  • Europe: Close behind North America, with numerous research institutions focusing on microbiome studies and a strong regulatory framework.
  • Asia Pacific: Rapidly emerging market due to increasing investment in biotechnology, rising awareness, and significant patient populations.
  • Rest of the World: Gradual growth observed, with particular interest in understanding region-specific microbiome profiles and their effects on health.

Key Players in the Global Microbiome Sequencing Services Market

The key features of the market report include patent analysis, grants analysis, clinical trials analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players.

The major companies in microbiome sequencing services market are as follows:

  • Illumina, Inc.
  • Thermo Fisher Scientific, Inc.
  • Pacific Biosciences of California, Inc.
  • Oxford Nanopore Technologies Ltd.
  • Qiagen N.V.
  • BaseClear B.V.
  • Zymo Research Corporation
  • Second Genome
  • Microbiome Insights Inc.
  • CosmosID Inc.
The publisher always strives to provide you with the latest information. The numbers in the article are only indicative and may be different from the actual report.

Table of Contents

1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage - Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Microbiome Sequencing Services Market Overview
3.1 Global Microbiome Sequencing Services Market Historical Value (2017-2023)
3.2 Global Microbiome Sequencing Services Market Forecast Value (2024-2032)
4 Global Microbiome Sequencing Services Market Landscape
4.1 Global Microbiome Sequencing Services Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Microbiome Sequencing Services Product Landscape
4.2.1 Analysis by Product and Services
4.2.2 Analysis by Technology
4.2.3 Analysis by Applications
5 Global Microbiome Sequencing Services Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.3 Porter’s Five Forces Model
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Microbiome Sequencing Services Market Segmentation
6.1 Global Microbiome Sequencing Services Market by Products and Services
6.1.1 Market Overview
6.1.2 Reagents and Consumables
6.1.3 Instruments
6.1.4 Services
6.2 Global Microbiome Sequencing Services Market by Technology
6.2.1 Market Overview
6.2.2 Sequencing by Synthesis
6.2.3 Sequencing by Ligation
6.2.4 Shotgun Sequencing
6.2.5 Sanger Sequencing
6.2.6 Pyrosequencing
6.2.7 Other Technologies
6.3 Global Microbiome Sequencing Services Market by Applications
6.3.1 Market Overview
6.3.2 Drug Development
6.3.3 Agriculture and Food Industry
6.3.4 Environmental Monitoring
6.3.5 Others
6.4 Global Microbiome Sequencing Services Market by End Use
6.4.1 Market Overview
6.4.2 Academic and Research Institutes
6.4.3 Pharmaceutical and Biotechnology Companies
6.4.4 Contract Research Organizations (CROs)
6.4.5 Others
6.5 Global Microbiome Sequencing Services Market by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Microbiome Sequencing Services Market
7.1 Market Share by Country
7.2 United States of America
7.3 Canada
8 Europe Microbiome Sequencing Services Market
8.1 Market Share by Country
8.2 United Kingdom
8.3 Germany
8.4 France
8.5 Italy
8.6 Others
9 Asia Pacific Microbiome Sequencing Services Market
9.1 Market Share by Country
9.2 China
9.3 Japan
9.4 India
9.5 ASEAN
9.6 Australia
9.7 Others
10 Latin America Microbiome Sequencing Services Market
10.1 Market Share by Country
10.2 Brazil
10.3 Argentina
10.4 Mexico
10.5 Others
11 Middle East and Africa Microbiome Sequencing Services Market
11.1 Market Share by Country
11.2 Saudi Arabia
11.3 United Arab Emirates
11.4 Nigeria
11.5 South Africa
11.6 Others
12 Grants Analysis
12.1 Analysis by year
12.2 Analysis by Amount Awarded
12.3 Analysis by Issuing Authority
12.4 Analysis by Grant Application
12.5 Analysis by Funding Institute
12.6 Analysis by NIH Departments
12.7 Analysis by Recipient Organization
13 Funding Analysis
13.1 Analysis by Funding Instances
13.2 Analysis by Type of Funding
13.3 Analysis by Funding Amount
13.4 Analysis by Leading Players
13.5 Analysis by Leading Investors
13.6 Analysis by Geography
14 Partnership and Collaborations Analysis
14.1 Analysis by Partnership Instances
14.2 Analysis by Type of Partnership
14.3 Analysis by Leading Players
14.4 Analysis by Geography
15 Regulatory Framework
15.1 Regulatory Overview
15.1.1 US FDA
15.1.2 EU EMA
15.1.3 INDIA CDSCO
15.1.4 JAPAN PMDA
15.1.5 Others
16 Supplier Landscape
16.1 Illumina, Inc.
16.1.1 Financial Analysis
16.1.2 Product Portfolio
16.1.3 Demographic Reach and Achievements
16.1.4 Mergers and Acquisition
16.1.5 Certifications
16.2 Thermo Fisher Scientific, Inc.
16.2.1 Financial Analysis
16.2.2 Product Portfolio
16.2.3 Demographic Reach and Achievements
16.2.4 Mergers and Acquisition
16.2.5 Certifications
16.3 Pacific Biosciences of California, Inc.
16.3.1 Financial Analysis
16.3.2 Product Portfolio
16.3.3 Demographic Reach and Achievements
16.3.4 Mergers and Acquisition
16.3.5 Certifications
16.4 Oxford Nanopore Technologies Ltd.
16.4.1 Financial Analysis
16.4.2 Product Portfolio
16.4.3 Demographic Reach and Achievements
16.4.4 Mergers and Acquisition
16.4.5 Certifications
16.5 Qiagen N.V.
16.5.1 Financial Analysis
16.5.2 Product Portfolio
16.5.3 Demographic Reach and Achievements
16.5.4 Mergers and Acquisition
16.5.5 Certifications
16.6 BaseClear B.V.
16.6.1 Financial Analysis
16.6.2 Product Portfolio
16.6.3 Demographic Reach and Achievements
16.6.4 Mergers and Acquisition
16.6.5 Certifications
16.7 Zymo Research Corporation
16.7.1 Financial Analysis
16.7.2 Product Portfolio
16.7.3 Demographic Reach and Achievements
16.7.4 Mergers and Acquisition
16.7.5 Certifications
16.8 Second Genome
16.8.1 Financial Analysis
16.8.2 Product Portfolio
16.8.3 Demographic Reach and Achievements
16.8.4 Mergers and Acquisition
16.8.5 Certifications
16.9 Microbiome Insights Inc.
16.9.1 Financial Analysis
16.9.2 Product Portfolio
16.9.3 Demographic Reach and Achievements
16.9.4 Mergers and Acquisition
16.9.5 Certifications
16.10 CosmosID Inc.
16.10.1 Financial Analysis
16.10.2 Product Portfolio
16.10.3 Demographic Reach and Achievements
16.10.4 Mergers and Acquisition
16.10.5 Certifications
17 Global Microbiome Sequencing Services Market - Distribution Model (Additional Insight)
17.1 Overview
17.2 Potential Distributors
17.3 Key Parameters for Distribution Partner Assessment
18 Key Opinion Leaders (KOL) Insights (Additional Insight)
19 Company Competitiveness Analysis (Additional Insight)
19.1 Very Small Companies
19.2 Small Companies
19.3 Mid-Sized Companies
19.4 Large Companies
19.5 Very Large Companies
20 Payment Methods (Additional Insight)
20.1 Government Funded
20.2 Private Insurance
20.3 Out-of-Pocket

Companies Mentioned

  • Illumina Inc.
  • Thermo Fisher Scientific Inc.
  • Pacific Biosciences of California Inc.
  • Oxford Nanopore Technologies Ltd.
  • Qiagen N.V.
  • BaseClear B.V.
  • Zymo Research Corporation
  • Second Genome
  • Microbiome Insights Inc.
  • CosmosID Inc.

Methodology

Loading
LOADING...